Skip to search formSkip to main contentSkip to account menu

PRLX 93936

Known as: Erastin Analogue PRLX 93936 
A structural analogue of erastin with potential antineoplastic activity. Erastin analogue PRLX 93936 appears to inhibit mitochondrial outer membrane… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A validated UPLC-MS/MS method coupled with protein precipitation and ion exchange solid phase extraction for the quantitation of porcine relaxin B29 in dog plasma and its application to a…
AbstractPorcine relaxin is a 6 kDa peptide hormone of pregnancy with important physiological and pharmacological effects. It… 
2009
2009
Abstract #4694: Therapeutic potential of a novel small molecule, PRLX 93936, in models of pancreatic cancer
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO PRLX 93936 displays robust activity in a diverse array of in vitro and in vivo… 
2009
2009
Abstract #4693: A novel small molecule, PRLX 93936, displays antitumor activity in vitro and in vivo against multiple models of melanoma
PRLX 93936 has demonstrated therapeutic potential in models of human tumors including examples with limited treatment options… 
2007
2007
Antitumor activity of a novel small molecule agent PRLX 93936 against human tumor xenograft models
B38 PRLX 93936 was identified as a potential anti-cancer therapeutic in a synthetic lethal screen against isogenic cell lines… 
2007
2007
PRLX 93936, a novel, small molecule with broad antitumor activity in vitro
A7 PRLX 93936 was identified as a potential anti-cancer therapeutic in a synthetic lethal screen against isogenic cell lines… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)